May 3 |
ANVS
|
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises |
May 2 |
ANVS
|
Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market |
May 2 |
ANVS
|
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates |
May 2 |
ANVS
|
Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects |
May 2 |
ANVS
|
Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales |
May 2 |
ANVS
|
Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question |
Apr 30 |
ANVS
|
Annovis Bio: Searching For Efficacy In Alzheimer's Disease |
Apr 29 |
ANVS
|
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session |
Apr 29 |
ANVS
|
Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study |
Apr 29 |
ANVS
|
Annovis Bio tumbles 53% on data for Alzheimer's candidate buntanetap |
Apr 29 |
ANVS
|
UPDATE 2-Annovis tumbles as Alzheimer's treatment misses in mid-stage study |
Apr 29 |
ANVS
|
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease |